227 related articles for article (PubMed ID: 8613740)
21. Direct cutaneous hyperalgesia induced by adenosine.
Taiwo YO; Levine JD
Neuroscience; 1990; 38(3):757-62. PubMed ID: 1980146
[TBL] [Abstract][Full Text] [Related]
22. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
[TBL] [Abstract][Full Text] [Related]
23. DAMGO inhibits prostaglandin E2-induced potentiation of a TTX-resistant Na+ current in rat sensory neurons in vitro.
Gold MS; Levine JD
Neurosci Lett; 1996 Jul; 212(2):83-6. PubMed ID: 8832644
[TBL] [Abstract][Full Text] [Related]
24. Antinociception produced by receptor selective opioids: modulation of spinal antinociceptive effects by supraspinal opioids.
Miaskowski C; Levine JD
Brain Res; 1992 Nov; 595(1):32-8. PubMed ID: 1334770
[TBL] [Abstract][Full Text] [Related]
25. Adenosine-A1 receptor agonist induced hyperalgesic priming type II.
Araldi D; Ferrari LF; Levine JD
Pain; 2016 Mar; 157(3):698-709. PubMed ID: 26588695
[TBL] [Abstract][Full Text] [Related]
26. Role of kappa and delta opioid receptors in mediating morphine-induced antinociception in morphine-tolerant infant rats.
Stoller DC; Sim-Selley LJ; Smith FL
Brain Res; 2007 Apr; 1142():28-36. PubMed ID: 17300766
[TBL] [Abstract][Full Text] [Related]
27. Selective attenuation of mu-opioid receptor-mediated effects in rat sensory neurons by intrathecal administration of antisense oligodeoxynucleotides.
Khasar SG; Gold MS; Dastmalchi S; Levine JD
Neurosci Lett; 1996 Oct; 218(1):17-20. PubMed ID: 8939470
[TBL] [Abstract][Full Text] [Related]
28. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
Mellon RD; Bayer BM
Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057
[TBL] [Abstract][Full Text] [Related]
29. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
30. DAMGO-induced μ opioid receptor internalization and recycling restore morphine sensitivity in tolerant rat.
Ma X; Chen R; Huang M; Wang W; Luo L; Kim DK; Jiang W; Xu T
Eur J Pharmacol; 2020 Jul; 878():173118. PubMed ID: 32320702
[TBL] [Abstract][Full Text] [Related]
31. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
32. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P
Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282
[TBL] [Abstract][Full Text] [Related]
33. Central regulation of urine production by a selective mu-opioid agonist, [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin, in rats.
Tsushima H; Mori M; Matsuda T
Jpn J Pharmacol; 1997 May; 74(1):45-9. PubMed ID: 9195296
[TBL] [Abstract][Full Text] [Related]
34. Antinociceptive tolerance to the mu-opioid agonist DAMGO is dose-dependently reduced by MK-801 in rats.
Mao J; Price DD; Lu J; Mayer DJ
Neurosci Lett; 1998 Jul; 250(3):193-6. PubMed ID: 9708865
[TBL] [Abstract][Full Text] [Related]
35. Nicotine withdrawal hyperalgesia and opioid-mediated analgesia depend on nicotine receptors in nucleus accumbens.
Schmidt BL; Tambeli CH; Gear RW; Levine JD
Neuroscience; 2001; 106(1):129-36. PubMed ID: 11564423
[TBL] [Abstract][Full Text] [Related]
36. Mediation of serotonin hyperalgesia by the cAMP second messenger system.
Taiwo YO; Heller PH; Levine JD
Neuroscience; 1992; 48(2):479-83. PubMed ID: 1318516
[TBL] [Abstract][Full Text] [Related]
37. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance.
Manning BH; Mao J; Frenk H; Price DD; Mayer DJ
Pain; 1996 Sep; 67(1):79-88. PubMed ID: 8895234
[TBL] [Abstract][Full Text] [Related]
38. Opioid-Induced Pronociceptive Signaling in the Gastrointestinal Tract Is Mediated by Delta-Opioid Receptor Signaling.
Jaramillo-Polanco J; Lopez-Lopez C; Yu Y; Neary E; Hegron A; Canals M; Bunnett NW; Reed DE; Lomax AE; Vanner SJ
J Neurosci; 2022 Apr; 42(16):3316-3328. PubMed ID: 35256532
[TBL] [Abstract][Full Text] [Related]
39. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
[TBL] [Abstract][Full Text] [Related]
40. Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat.
Miaskowski C; Taiwo YO; Levine JD
Eur J Pharmacol; 1991 Dec; 205(3):247-52. PubMed ID: 1667910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
